Octreotide LAR in the Induction of Immunologic Response in NENs Patients

Condition:   Neuroendocrine Tumors Intervention:   Drug: Octreotide Acetate Sponsor:   National Cancer Institute, Naples Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials